Bono M, Fanale D, Incorvaia L, Cancelliere D, Fiorino A, Calo V, et al. Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge. ESMO Open. 2021;6:100235.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moynahan ME, Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol. 2010;11:196–207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.

Article  CAS  PubMed  Google Scholar 

Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–92.

Article  CAS  PubMed  Google Scholar 

Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220–8.

Article  CAS  PubMed  Google Scholar 

Creeden JF, Nanavaty NS, Einloth KR, Gillman CE, Stanbery L, Hamouda DM, et al. Homologous recombination proficiency in ovarian and breast cancer patients. BMC Cancer. 2021;21:1154.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zayas-Villanueva OA, Campos-Acevedo LD, Lugo-Trampe JJ, Hernandez-Barajas D, Gonzalez-Guerrero JF, Noriega-Iriondo MF, et al. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study. BMC Cancer. 2019;19:722.

Article  PubMed  PubMed Central  Google Scholar 

Anantha RW, Simhadri S, Foo TK, Miao S, Liu J, Shen Z, et al. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. Elife. 2017;6:e21350.

Article  PubMed  PubMed Central  Google Scholar 

Farrugia DJ, Agarwal MK, Pankratz VS, Deffenbaugh AM, Pruss D, Frye C, et al. Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res. 2008;68:3523–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ikegami M, Kohsaka S, Ueno T, Momozawa Y, Inoue S, Tamura K, et al. High-throughput functional evaluation of BRCA2 variants of unknown significance. Nat Commun. 2020;11:2573.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Truty R, Ouyang K, Rojahn S, Garcia S, Colavin A, Hamlington B, et al. Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation. Am J Hum Genet. 2021;108:696–708.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iversen ES Jr., Lipton G, Hart SN, Lee KY, Hu C, Polley EC, et al. An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance. NPJ Genom Med. 2022;7:35.

Article  PubMed  PubMed Central  Google Scholar 

Guidugli L, Shimelis H, Masica DL, Pankratz VS, Lipton GB, Singh N, et al. Assessment of the clinical relevance of BRCA2 missense variants by functional and computational approaches. Am J Hum Genet. 2018;102:233–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980–5.

Article  CAS  PubMed  Google Scholar 

Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2006;43:295–305.

Article  CAS  PubMed  Google Scholar 

Shihab HA, Rogers MF, Gough J, Mort M, Cooper DN, Day IN, et al. An integrative approach to predicting the functional effects of non-coding and coding sequence variation. Bioinformatics. 2015;31:1536–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang H, Thomas PD. PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics. 2016;32:2230–2.

Article  CAS  PubMed  Google Scholar 

Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akaike H. Information theory and an extension of the maximum likelihood principle. In: Parzen E, Tanabe K, Kitagawa G, editors. Selected Papers of Hirotugu Akaike. Springer Series in Statistics. New York: Springer; 1998. p. 199–213.

Gentleman RIR. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5:299–314.

Google Scholar 

Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.

Article  CAS  PubMed  Google Scholar 

Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun. 2018;9:4083.

Article  PubMed  PubMed Central  Google Scholar 

Eilbeck K, Quinlan A, Yandell M. Settling the score: variant prioritization and Mendelian disease. Nat Rev Genet. 2017;18:599–612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

Article  PubMed  PubMed Central  Google Scholar 

Frazer J, Notin P, Dias M, Gomez A, Min JK, Brock K, et al. Disease variant prediction with deep generative models of evolutionary data. Nature. 2021;599:91–5.

Article  CAS  PubMed  Google Scholar 

Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115:2222–33.

Article  CAS  PubMed  Google Scholar 

Bouwman P, van der Heijden I, van der Gulden H, de Bruijn R, Braspenning ME, Moghadasi S, et al. Functional categorization of BRCA1 variants of uncertain clinical significance in homologous recombination repair complementation assays. Clin Cancer Res. 2020;26:4559–68.

Article  CAS  PubMed  Google Scholar 

Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, et al. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 2017;77:2789–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andreassen PR, Seo J, Wiek C, Hanenberg H. Understanding BRCA2 function as a tumor suppressor based on domain-specific activities in DNA damage responses. Genes (Basel). 2021;12:1034.

Article  CAS  PubMed  Google Scholar 

Poon KS. In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing. Sci Rep. 2021;11:11114.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Houdayer C, Caux-Moncoutier V, Krieger S, Barrois M, Bonnet F, Bourdon V, et al. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat. 2012;33:1228–38.

Article  CAS  PubMed  Google Scholar 

Thomassen M, Kruse TA, Jensen PK, Gerdes AM. A missense mutation in exon 13 in BRCA2, c.7235G>A, results in skipping of exon 13. Genet Test. 2006;10:116–20.

Article  CAS  PubMed  Google Scholar 

Fraile-Bethencourt E, Diez-Gomez B, Velasquez-Zapata V, Acedo A, Sanz DJ, Velasco EA. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18. PLoS Genet. 2017;13:e1006691.

Article  PubMed  PubMed Central  Google Scholar